Dr. Evan Dellon highlights potential risks with cumulative use of steroids for treatment of various coexisting type 2 inflammatory diseases.
Join global expert Evan Dellon, MD, MPH, as he highlights different ways that corticosteroids may be taken by a patient for various type 2 inflammatory diseases, and discusses the cumulative risk for steroid complications.
Professor of Medicine and Adjunct Professor of Epidemiology | University of North Carolina School of Medicine, Chapel Hill, United States
See author’s profile